NR3C1 and breast carcinoma: In the context of breast cancer, NR3C1 promotor methylation (Nesset et al, 2014) has been suggested to play a role in its transcriptional silencing; however, other possible mechanisms of inactivation may also exist and should be dissected in further studies.